{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:45:58Z","timestamp":1793202358496,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jacc.2023.08.014","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T13:57:29Z","timestamp":1696859849000},"page":"1628-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["International Consensus on Differential Diagnosis and Management of Patients With Danon Disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Kimberly N.","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-3080","authenticated-orcid":false,"given":"Emily A.","family":"Eshraghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Arad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Argir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Brambatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Caspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4350-3217","authenticated-orcid":false,"given":"Fernando","family":"de Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Yesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-2257","authenticated-orcid":false,"given":"Pablo","family":"Garcia-Pavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacc.2023.08.014_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal glycogen storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jacc.2023.08.014_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.10235","article-title":"Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease)","volume":"52","author":"Takahashi","year":"2002","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.jacc.2023.08.014_bib3","first-page":"2457","article-title":"Danon disease-associated LAMP-2 deficiency drives metabolic signature indicative of mitochondrial aging and fibrosis in cardiac tissue and hiPSC-derived cardiomyocytes","volume":"9","author":"Del Favero","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"535","key":"10.1016\/j.jacc.2023.08.014_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax1744","article-title":"Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease","volume":"12","author":"Manso","year":"2020","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.jacc.2023.08.014_bib5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.114.001105","article-title":"Danon disease: clinical features, evaluation, and management","volume":"7","author":"D\u2019souza","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.jacc.2023.08.014_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/nan.12587","article-title":"Review: Danon disease: review of natural history and recent advances","volume":"46","author":"Cenacchi","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"10.1016\/j.jacc.2023.08.014_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2023.08.014_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2019.01.020","article-title":"Danon disease: gender differences in presentation and outcomes","volume":"286","author":"Brambatti","year":"2019","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.jacc.2023.08.014_bib9","first-page":"479","article-title":"Clinical findings and prognosis of Danon disease. an analysis of the Spanish Multicenter Danon Registry","volume":"72","author":"L\u00f3pez-Sainz \u00c1","year":"2019","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"6","key":"10.1016\/j.jacc.2023.08.014_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003117","article-title":"Clinical profile of cardiac involvement in Danon disease: a multicenter European registry","volume":"13","author":"Lotan","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"11","key":"10.1016\/j.jacc.2023.08.014_bib11","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.105.546481","article-title":"Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children","volume":"112","author":"Yang","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1399-3046.2007.00874.x","article-title":"Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation","volume":"12","author":"Bui","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jacc.2023.08.014_bib13","article-title":"Case report: Danon disease: six family members and literature review","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.08.014_bib14","author":"Taylor"},{"issue":"11","key":"10.1016\/j.jacc.2023.08.014_bib15","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.3390\/ijms19113507","article-title":"A\u00a0nationwide survey on Danon disease in Japan","volume":"19","author":"Sugie","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jacc.2023.08.014_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00401-015-1385-4","article-title":"Danon disease: a phenotypic expression of LAMP-2 deficiency","volume":"129","author":"Endo","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"6798","key":"10.1016\/j.jacc.2023.08.014_bib17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jacc.2023.08.014_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/21678707.2021.1882994","article-title":"Recommendations and guidance on the diagnosis and management of Danon disease","volume":"9","author":"Hong","year":"2021","journal-title":"Expert Opin Orphan Drugs"},{"issue":"6","key":"10.1016\/j.jacc.2023.08.014_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.nmd.2015.03.005","article-title":"Early onset cardiomyopathy in females with Danon disease","volume":"25","author":"Hedberg Oldfors","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2020.08.011","article-title":"Cardiac magnetic resonance imaging in Danon disease cardiomyopathy","volume":"14","author":"Rigolli","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"17","key":"10.1016\/j.jacc.2023.08.014_bib21","article-title":"LAMP2 cardiomyopathy: consequences of impaired autophagy in the heart","volume":"10","author":"Alcalai","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.014_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2017.06.031","article-title":"Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy)","volume":"245","author":"Samad","year":"2017","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2023.08.014_bib23","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/jce.14049","article-title":"Arrhythmias and fasciculoventricular pathways in patients with Danon disease: a single center experience","volume":"30","author":"Jhaveri","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.jacc.2023.08.014_bib24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10038-007-0184-8","article-title":"Danon disease presenting with dilated cardiomyopathy and a complex phenotype","volume":"52","author":"Taylor","year":"2007","journal-title":"J\u00a0Hum Genet"},{"issue":"5","key":"10.1016\/j.jacc.2023.08.014_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.carpath.2016.07.005","article-title":"A\u00a0novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: a case report and literature review","volume":"25","author":"Bottillo","year":"2016","journal-title":"Cardiovasc Pathol"},{"issue":"6","key":"10.1016\/j.jacc.2023.08.014_bib26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/mus.21811","article-title":"Functional performance and muscle strength phenotypes in men and women with Danon disease","volume":"42","author":"Stevens-Lapsley","year":"2010","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.jacc.2023.08.014_bib27","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/ajmg.a.38320","article-title":"Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation)","volume":"173","author":"Yardeni","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.jacc.2023.08.014_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1399-0004.2008.00971.x","article-title":"Cardioembolic stroke in Danon disease","volume":"73","author":"Spinazzi","year":"2008","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacc.2023.08.014_bib29","article-title":"Transient ischemic attack and ischemic stroke in Danon disease with formation of left ventricular apical thrombus despite normal systolic function","volume":"2017","author":"Tsuda","year":"2017","journal-title":"Case Rep Pediatr"},{"issue":"6","key":"10.1016\/j.jacc.2023.08.014_bib30","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ophtha.2006.02.030","article-title":"Ophthalmic manifestations of Danon disease","volume":"113","author":"Prall","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jacc.2023.08.014_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/1120672119832183","article-title":"Retinal dystrophy associated with Danon disease and pathogenic mechanism through LAMP2-mutated retinal pigment epithelium","volume":"30","author":"Fukushima","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jacc.2023.08.014_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/aos.14478","article-title":"Pigmentary retinopathy can indicate the presence of pathogenic LAMP2 variants even in somatic mosaic carriers with no additional signs of Danon disease","volume":"99","author":"Kousal","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.jacc.2023.08.014_bib33","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/ehf2.12823","article-title":"Danon disease is an underdiagnosed cause of advanced heart failure in young female patients: a LAMP2 flow cytometric study","volume":"7","author":"Gurka","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib34","first-page":"168","article-title":"Early diagnosis of Danon disease: flow cytometric detection of lysosome-associated membrane protein-2-negative leukocytes","volume":"66","author":"Hashida","year":"2015","journal-title":"J\u00a0Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.gene.2012.02.004","article-title":"Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency","volume":"498","author":"Majer","year":"2012","journal-title":"Gene"},{"issue":"18","key":"10.1016\/j.jacc.2023.08.014_bib36","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.115.019847","article-title":"Amelioration of X-linked related autophagy failure in Danon disease with DNA methylation inhibitor","volume":"134","author":"Ng","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2023.08.014_bib37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2353\/ajpath.2006.050646","article-title":"Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease","volume":"168","author":"Fanin","year":"2006","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.jacc.2023.08.014_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003121","article-title":"Clinical spectrum of PRKAG2 syndrome","volume":"9","author":"Porto","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jacc.2020.05.029","article-title":"Clinical features and natural history of PRKAG2 variant cardiac glycogenosis","volume":"76","author":"Lopez-Sainz","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2023.08.014_bib40","first-page":"506","article-title":"Late-onset Pompe\u2019s disease","volume":"32","author":"Teener","year":"2012","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.jacc.2023.08.014_bib41","first-page":"202","article-title":"S1.4 Cardiovascular involvement in Pompe disease","volume":"30","author":"Limongelli","year":"2011","journal-title":"Acta Myologica"},{"key":"10.1016\/j.jacc.2023.08.014_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fcvm.2016.00025","article-title":"Mitochondrial cardiomyopathies","volume":"3","author":"El-Hattab","year":"2016","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.jacc.2023.08.014_bib43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/heartjnl-2015-308193","article-title":"Mitochondrial disease and the heart","volume":"103","author":"Limongelli","year":"2017","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.jacc.2023.08.014_bib44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.2004-0718","article-title":"Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease","volume":"114","author":"Scaglia","year":"2004","journal-title":"Pediatrics"},{"issue":"42","key":"10.1016\/j.jacc.2023.08.014_bib45","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1093\/eurheartj\/ehv307","article-title":"Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases","volume":"36","author":"Wahbi","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacc.2023.08.014_bib46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/archdischild-2021-322455","article-title":"Friedreich\u2019s ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study","volume":"107","author":"Norrish","year":"2022","journal-title":"Arch Dis Child"},{"issue":"11","key":"10.1016\/j.jacc.2023.08.014_bib47","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2015.1855","article-title":"A\u00a022-year follow-up study of long-term cardiac outcome and predictors of survival in Friedreich ataxia","volume":"72","author":"Pousset","year":"2015","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.jacc.2023.08.014_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hfc.2021.07.004","article-title":"Hypertrophic cardiomyopathy in RASopathies","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail Clin"},{"issue":"4","key":"10.1016\/j.jacc.2023.08.014_bib49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ajmg.c.32014","article-title":"The heart in RASopathies","volume":"190","author":"Delogu","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jacc.2023.08.014_bib50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.jacc.2023.08.014_bib51","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in Fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.014_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.708679","article-title":"Childhood hypertrophic cardiomyopathy: a disease of the cardiac sarcomere","volume":"9","author":"Norrish","year":"2021","journal-title":"Front Pediatr"},{"issue":"20","key":"10.1016\/j.jacc.2023.08.014_bib53","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/eurheartj\/ehab148","article-title":"Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy","volume":"42","author":"Marston","year":"2021","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jacc.2023.08.014_bib54","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.jacc.2020.08.044","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacc.2023.08.014_bib55","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2023.08.014_bib56","article-title":"Dilated cardiomyopathy and systolic heart failure in a female patient with Danon disease","volume":"14","author":"Stack-Pyle","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jacc.2023.08.014_bib57","doi-asserted-by":"crossref","first-page":"ytz132","DOI":"10.1093\/ehjcr\/ytz132","article-title":"Three female patients with Danon disease presenting with predominant cardiac phenotype: a case series","volume":"3","author":"Mulder","year":"2019","journal-title":"Eur Heart J Case Rep"},{"issue":"8","key":"10.1016\/j.jacc.2023.08.014_bib58","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/hrt.2003.029504","article-title":"Danon\u2019s disease as a cause of hypertrophic cardiomyopathy: a systematic survey","volume":"90","author":"Charron","year":"2004","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.jacc.2023.08.014_bib59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.014_bib60","unstructured":"Cardiovascular Genomics and Precision Medicine Group. The Atlas of Cardiac Genetic Variation: Dilated Cardiomyopathy - DCM. London: Institute of Medical Sciences."},{"key":"10.1016\/j.jacc.2023.08.014_bib61","first-page":"11","article-title":"Danon disease due to a novel LAMP2 microduplication","volume":"14","author":"Lines","year":"2013","journal-title":"JIMD Rep"},{"issue":"1","key":"10.1016\/j.jacc.2023.08.014_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajmg.a.61416","article-title":"Alu-mediated Xq24 deletion encompassing CUL4B, LAMP2, ATP1B4, TMEM255A, and ZBTB33 genes causes Danon disease in a female patient","volume":"182","author":"Majer","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCGENETICS.109.901785","article-title":"LAMP2 microdeletions in patients with Danon disease","volume":"3","author":"Yang","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"S1","key":"10.1016\/j.jacc.2023.08.014_bib64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10545-009-1097-9","article-title":"Danon disease: case report and detection of new mutation","volume":"32","author":"Regelsberger","year":"2009","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"11","key":"10.1016\/j.jacc.2023.08.014_bib65","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/ajmg.a.40430","article-title":"LAMP2 exon-copy number variations in Danon disease heterozygote female probands: infrequent or underdetected?","volume":"176","author":"Majer","year":"2018","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jacc.2023.08.014_bib66","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","author":"Mehta","year":"2006"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/20009666.2017.1324239","article-title":"Danon disease for the cardiologist: case report and review of the literature","volume":"7","author":"D\u2019souza","year":"2017","journal-title":"J\u00a0Community Hosp Intern Med Perspect"},{"issue":"4","key":"10.1016\/j.jacc.2023.08.014_bib68","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cardfail.2021.11.007","article-title":"Cardiac transplantation in Danon disease","volume":"28","author":"Hong","year":"2022","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.jacc.2023.08.014_bib69","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2011.09.024","article-title":"Sudden death associated with Danon disease in women","volume":"109","author":"Miani","year":"2012","journal-title":"Am J Cardiol"},{"issue":"39","key":"10.1016\/j.jacc.2023.08.014_bib70","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.jacc.2023.08.014_bib71","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. a position statement from the ESC working group on myocardial and pericardial diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.014_bib72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2022.03.050","article-title":"Diagnosis and management of rare cardiomyopathies in adult and paediatric patients. a position paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP)","volume":"357","author":"Limongelli","year":"2022","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2023.08.014_bib73","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.hrthm.2021.03.024","article-title":"Fasciculoventricular and atrioventricular accessory pathways in patients with Danon disease and preexcitation: a multicenter experience","volume":"18","author":"Darden","year":"2021","journal-title":"Heart Rhythm"},{"issue":"24","key":"10.1016\/j.jacc.2023.08.014_bib74","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.jacc.2013.04.004","article-title":"B-type natriuretic peptide and survival in hypertrophic cardiomyopathy","volume":"61","author":"Geske","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2023.08.014_bib75","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.hrthm.2018.04.030","article-title":"B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy","volume":"15","author":"Minami","year":"2018","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.jacc.2023.08.014_bib76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression","volume":"14","author":"Fontana","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"23","key":"10.1016\/j.jacc.2023.08.014_bib77","article-title":"Myocardial strain and association with clinical outcomes in Danon disease: a model for monitoring progression of genetic cardiomyopathies","volume":"10","author":"Bui","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.jacc.2023.08.014_bib78","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.jcmg.2020.05.027","article-title":"Apical sparing strain pattern in Danon disease: insights from a global registry","volume":"13","author":"Bui","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"11","key":"10.1016\/j.jacc.2023.08.014_bib79","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart\u00a0Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"30","key":"10.1016\/j.jacc.2023.08.014_bib80","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel\u00a0clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jacc.2023.08.014_bib81","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM risk-kids)","volume":"4","author":"Norrish","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2023.08.014_bib82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A\u00a0validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jacc.2023.08.014_bib83","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.014_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115229","article-title":"Autophagy guided interventions to modify the cardiac phenotype of Danon disease","volume":"204","author":"Yadin","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.jacc.2023.08.014_bib85","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/CIRCRESAHA.119.313569","article-title":"Novel therapies for prevention and early treatment of cardiomyopathies","volume":"124","author":"Repetti","year":"2019","journal-title":"Circ Res"},{"issue":"10024","key":"10.1016\/j.jacc.2023.08.014_bib86","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamacardio.2016.0008","article-title":"Intracoronary gene transfer of adenylyl cyclase 6 in patients with heart failure: a randomized clinical trial","volume":"1","author":"Hammond","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2023.08.014_bib88","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ymthe.2017.03.027","article-title":"Cardiovascular gene therapy: past, present, and future","volume":"25","author":"Yl\u00e4-Herttuala","year":"2017","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.jacc.2023.08.014_bib89","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00424-018-2173-5","article-title":"Gene therapy strategies in the treatment of hypertrophic cardiomyopathy","volume":"471","author":"Prondzynski","year":"2019","journal-title":"Pflugers Arch"},{"issue":"2","key":"10.1016\/j.jacc.2023.08.014_bib91","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1715","article-title":"Hypertrophic cardiomyopathy: the future of treatment","volume":"22","author":"Tuohy","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2023.08.014_bib92","article-title":"Abstract 11117: Phase 1 Danon disease results: the first single dose intravenous (IV) gene therapy (RP-A501) with recombinant adeno-associated virus (AAV9:LAMP2B) for a monogenic cardiomyopathy","volume":"146","author":"Rossano","year":"2022","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723064598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723064598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:58:43Z","timestamp":1760018323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109723064598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":91,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0735109723064598"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2023.08.014","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Consensus on Differential Diagnosis and Management of Patients With Danon Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}